Short Interest in Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Expands By 417.6%

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBTGet Free Report) was the recipient of a significant increase in short interest in July. As of July 31st, there was short interest totaling 296,924 shares, an increase of 417.6% from the July 15th total of 57,363 shares. Currently, 0.6% of the shares of the company are short sold. Based on an average daily volume of 19,111,558 shares, the days-to-cover ratio is currently 0.0 days.

Zhengye Biotechnology Stock Down 1.3%

Shares of NASDAQ:ZYBT traded down $0.02 during mid-day trading on Thursday, reaching $1.53. 158,697 shares of the company traded hands, compared to its average volume of 2,225,819. The company’s 50 day moving average price is $1.23 and its 200-day moving average price is $1.02. The company has a current ratio of 1.14, a quick ratio of 0.82 and a debt-to-equity ratio of 0.03. Zhengye Biotechnology has a 52 week low of $0.62 and a 52 week high of $13.08.

Hedge Funds Weigh In On Zhengye Biotechnology

Several institutional investors have recently bought and sold shares of ZYBT. Citadel Advisors LLC bought a new stake in shares of Zhengye Biotechnology in the 3rd quarter worth about $31,000. Millennium Management LLC bought a new position in Zhengye Biotechnology during the 3rd quarter valued at about $38,000. WINTON GROUP Ltd purchased a new stake in Zhengye Biotechnology in the 3rd quarter worth about $56,000. Geode Capital Management LLC purchased a new stake in Zhengye Biotechnology in the 2nd quarter worth about $174,000. Finally, Invesco Ltd. bought a new stake in Zhengye Biotechnology in the second quarter worth about $220,000.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded Zhengye Biotechnology from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday, July 20th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Zhengye Biotechnology has an average rating of “Sell”.

Get Our Latest Stock Analysis on ZYBT

About Zhengye Biotechnology

(Get Free Report)

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.

Featured Stories

Receive News & Ratings for Zhengye Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhengye Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.